Cortechs.ai, a pioneer in advanced imaging software for medical analysis, is thrilled to announce a strategic partnership with Ascend Imaging, a renowned provider of radiology products and services. This collaboration will significantly strengthen Cortechs.ai’s ability to deliver its world-class imaging technology to hospitals and imaging centers across the country.
Ascend Imaging brings a formidable team of sales experts dedicated to driving growth and adoption of innovative imaging solutions. Their extensive network and strong market presence will be instrumental in expanding the reach of Cortechs.ai’s cutting-edge technology, including its flagship NeuroQuant solution.
“Our partnership with Ascend Imaging marks a significant milestone for Cortechs.ai,” stated Kyle Frye, CEO at Cortechs.ai. “Their dedication to excellence and deep industry expertise align perfectly with our mission to provide best-in-class support to healthcare providers. Through this collaboration, even more hospitals and imaging centers will have access to our advanced technologies centered around neuro and oncology, crucial to improving patient outcomes and streamlining diagnostic processes.”
Ascend Imaging’s broad industry reach will bolster Cortechs.ai’s position in the market, bringing transformative imaging solutions to more healthcare providers and driving excellence in patient care. “We are excited about our partnership with Cortechs.ai. By including their cutting-edge AI solutions into our offerings, we are poised to deliver unparalleled value and innovation to our clients,” said Wesley Adams, President, Ascend Imaging. “This collaboration marks a significant step forward in our mission to provide advanced AI solutions that meet the evolving needs of the healthcare industry.”
About Cortechs.ai
Cortechs.ai is a leader in AI applications within radiology. The company leverages cutting-edge technologies in medical imaging to revolutionize disease screening and early detection, empowering patients to enjoy longer, healthier lives. Cortechs.ai develops and markets groundbreaking medical device software that quantifies and tracks neurodegenerative diseases, while also assisting in the detection of clinically significant cancer.
Cortechs.ai’s industry-leading brain imaging software equips radiologists, neurologists, oncologists, and clinical researchers worldwide with a convenient and cost-effective way to quantify brain structures for assessing Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and other brain abnormalities. The company has FDA-cleared products for use in aiding the diagnosis and follow-up of neurodegenerative and traumatic brain conditions, as well as prostate cancer.
For more information, please visit www.cortechs.ai and follow us on Twitter, LinkedIn, and Facebook.
